Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service cervical fusion & disc arthroplasty cases in New Mexico: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 6% on average (210 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 3 | 172 | 40% |
| 2020 | 1 | 111 | 43% |
| 2021 | 4 | 149 | 46% |
| 2022 | 4 | 163 | 50% |
| 2023 | 3 | 140 | 53% |
| 2024 | 2 | 123 | 54% |
| 2025 from claims | – | 225 182–264 | 54% |
| 2026 forecast | – | 229 180–288 | 55% |
| 2027 forecast | – | 236 175–311 | 55% |
| 2028 forecast | – | 242 171–334 | 56% |
| 2029 forecast | – | 248 169–356 | 56% |
| 2030 forecast | – | 255 167–378 | 56% |
ACDF, posterior cervical fusion, cervical total disc replacement. Professional codes (what the surgeon bills): CPT 22551, 22600, 22856; the hospital bills MS-DRG 471, 472, 473, 429, 430.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in New Mexico; 2 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 49% inpatient hospital, 51% hospital outpatient.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| California | 77 | 3,603−4%/yr | −4%/yr | 1.0 | 0% | 4,270 in 2030+2.9%/yr |
| Arizona | 36 | 1,337+2.4%/yr | +2.4%/yr | 1.7 | 6% | 1,730 in 2030+4.4%/yr |
| Colorado | 24 | 1,147−1.6%/yr | −1.6%/yr | 2.3 | 1% | 1,280 in 2030+1.9%/yr |
| Washington | 12 | 886−6.9%/yr | −6.9%/yr | 1.1 | 11% | 890 in 20300%/yr |
| Oregon | 11 | 615−5.6%/yr | −5.6%/yr | 1.4 | 25% | 690 in 2030+2%/yr |
| Utah | 9 | 439−3.4%/yr | −3.4%/yr | 1.9 | 17% | 560 in 2030+4.1%/yr |
| Nevada | 3 | 378−6.4%/yr | −6.4%/yr | 1.3 | 0% | 370 in 2030−0.3%/yr |
| Idaho | 8 | 341−3.9%/yr | −3.9%/yr | 1.6 | 0% | 450 in 2030+4.8%/yr |
| Montana | 4 | 238−0.9%/yr | −0.9%/yr | 1.2 | 0% | 270 in 2030+2.1%/yr |
| Alaska | 5 | 221+8.1%/yr | +8.1%/yr | 1.8 | 0% | 400 in 2030+10%/yr |
| Wyoming | 2 | 111−8.1%/yr | −8.1%/yr | 1.0 | 0% | 160 in 2030+6.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 8 | 2820%/yr | 0%/yr | 1.20.4× | 0% | 180 in 2030−7.3%/yr |
| Decompression & minimally invasive spine | 7 | 250−13%/yr | −13%/yr | 1.00.3× | 0% | 350 in 2030+5.7%/yr |
| Kyphoplasty & vertebroplasty | 1 | 106−5.5%/yr | −5.5%/yr | 0.50.5× | 0% | 90 in 2030−3.6%/yr |
Cervical fusion & disc arthroplasty in every state, and its device makers · Every procedure market in New Mexico · Every state · Compare with California
Globus Medical leads with 64% of company spending on these surgeons in 2025, +55 pts on 2024.
In 2025, 7 companies reported engagement with New Mexico’s surgeons worth $11K in consulting, speaking, meals and travel tied to these products, about $5,297 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 69 clearances and approvals in the category, 4 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.